Status:
RECRUITING
Detection of EEG-Based Biomarkers of Chronic Low Back Pain
Lead Sponsor:
Stanford University
Collaborating Sponsors:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Conditions:
Chronic Low-back Pain
Healthy
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Chronic low back pain (CLBP) is a pervasive disorder affecting up to one-fifth of adults globally and is the single greatest cause of disability worldwide. Despite the high prevalence and detrimental ...
Eligibility Criteria
Inclusion
- Current diagnosis of Chronic Low Back Pain
Exclusion
- Current diagnosis of cancer
- Severe psychiatric conditions
- Pending personal litigation relating to an injury or receiving workers' compensation benefits
- Being a non-English speaker.
Key Trial Info
Start Date :
December 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT06025201
Start Date
December 15 2023
End Date
February 1 2026
Last Update
June 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Stanford's Systems and Neuroscience Pain Lab
Palo Alto, California, United States, 94304